NCOA1 and endometrial carcinoma: SRC-1 is highly expressed in normal endometrial tissues, with an average positive rate of 81.8%; unexpectedly, its expression is reduced in endometrial hyperplasia (58.9%) and endometrial carcinoma (45.0%) tissues [97].